Related Experiment Video
Updated: Jun 13, 2026
08:01
A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
Published on: August 12, 2016
Sweet future: fluctuating blood glucose levels affect future discounting.
1Department of Psychology, University of South Dakota, Vermillion, SD 57069, USA. xtwang@usd.edu
Psychological Science
|April 29, 2010
Summary
Blood glucose levels influence how people value future rewards. Consuming sugar reduced future discounting, while artificial sweeteners increased it, linking metabolic state to financial decision-making.
Area of Science:
- Behavioral Economics
- Neuroscience
- Metabolic Research
Background:
- Future discounting describes the tendency to prefer immediate rewards over larger future ones.
- Metabolic factors, such as blood glucose, may influence decision-making processes.
- Understanding these links can inform interventions for financial behavior.
Purpose of the Study:
- To investigate the relationship between blood glucose levels and future discounting rates.
- To explore metabolic mechanisms underlying choice behavior.
- To determine if caloric intake affects the valuation of future rewards.
Main Methods:
- Participants made choices between immediate and delayed monetary rewards.
- Blood glucose levels were monitored in relation to caloric intake (sugar vs. artificial sweetener).
- Statistical controls were applied for sex, age, and body mass index.
Main Results:
- Consuming a sugar-sweetened beverage led to a reduced rate of future discounting.
- Consuming a beverage with artificial sweetener increased the rate of future discounting.
- Blood glucose levels were found to directly regulate future discounting rates.
Conclusions:
- Blood glucose serves as a key index for the body's energy budget, influencing future discounting.
- Metabolic state significantly impacts economic decision-making.
- Caloric intake, specifically sugar, can modulate the preference for immediate versus delayed rewards.
Related Concept Videos
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...